EndoAICAR™ is a proprietary peptide blend under development by Pyxis Biologix that has shown strong anti-tumor effects. AICAR, an AMPK activator, has been shown to induce apoptosis in gallbladder cancer cells and lymphocyte leukemia cells. Studies have also indicated an ability to trigger non-apoptotic cell death in prostate cancer cells and multidrug resistant tumor cells, and stop the spread of breast cancer.